JP2023503601A5 - - Google Patents
Info
- Publication number
- JP2023503601A5 JP2023503601A5 JP2022530210A JP2022530210A JP2023503601A5 JP 2023503601 A5 JP2023503601 A5 JP 2023503601A5 JP 2022530210 A JP2022530210 A JP 2022530210A JP 2022530210 A JP2022530210 A JP 2022530210A JP 2023503601 A5 JP2023503601 A5 JP 2023503601A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- dimethylocta
- dien
- dihydroxy
- sulfonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962940545P | 2019-11-26 | 2019-11-26 | |
| US62/940,545 | 2019-11-26 | ||
| US202063110479P | 2020-11-06 | 2020-11-06 | |
| US63/110,479 | 2020-11-06 | ||
| PCT/CA2020/051607 WO2021102567A1 (en) | 2019-11-26 | 2020-11-25 | Cannabigerol derivatives and use thereof as cannabinoid receptor modulators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023503601A JP2023503601A (ja) | 2023-01-31 |
| JP2023503601A5 true JP2023503601A5 (cg-RX-API-DMAC7.html) | 2023-11-22 |
Family
ID=76128559
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022530210A Pending JP2023503601A (ja) | 2019-11-26 | 2020-11-25 | カンナビゲロール誘導体、およびカンナビノイド受容体モジュレーターとしてのその使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US12084407B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4065554A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023503601A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021102567A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3994114A4 (en) | 2019-07-04 | 2023-08-16 | Canopy Growth Corporation | CANNABINOID DERIVATIVES |
| WO2021007663A1 (en) | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
| EP3997098A4 (en) | 2019-07-12 | 2023-10-11 | Canopy Growth Corporation | Cannabinoid derivatives |
| WO2021007661A1 (en) | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
| JP2022551066A (ja) | 2019-10-02 | 2022-12-07 | キャノピー グロウス コーポレイション | カンナビノイド誘導体 |
| US12617765B2 (en) | 2019-12-09 | 2026-05-05 | Canopy Growth Corporation | Cannabinoid derivatives |
| IL312785B2 (en) | 2020-05-19 | 2026-06-01 | Cybin Irl Ltd | Deuterated tryptamine derivatives and methods of use |
| WO2022105810A1 (zh) * | 2020-11-17 | 2022-05-27 | 中国科学院上海药物研究所 | 一类间苯二酚化合物及其制备方法以及在神经系统疾病中的应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8481085B2 (en) * | 2006-06-15 | 2013-07-09 | Gw Pharma Limited | Pharmaceutical compositions comprising cannabigerol |
| DK2913321T3 (da) * | 2014-02-27 | 2021-10-25 | Emerald Health Pharmaceuticals Inc | Hidtil ukendte cannabigerolderivater |
| EP3994114A4 (en) | 2019-07-04 | 2023-08-16 | Canopy Growth Corporation | CANNABINOID DERIVATIVES |
| US20220242844A1 (en) | 2019-07-04 | 2022-08-04 | Canopy Growth Corporation | Cannabinoid derivatives |
| EP3997098A4 (en) | 2019-07-12 | 2023-10-11 | Canopy Growth Corporation | Cannabinoid derivatives |
| WO2021007663A1 (en) | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
| WO2021007659A1 (en) | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
| WO2021007660A1 (en) | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
| WO2021007661A1 (en) | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
| WO2021062557A1 (en) | 2019-10-02 | 2021-04-08 | Canopy Growth Corporation | Cannabinoid derivatives |
| JP2022551066A (ja) | 2019-10-02 | 2022-12-07 | キャノピー グロウス コーポレイション | カンナビノイド誘導体 |
| JP2023503330A (ja) | 2019-11-26 | 2023-01-27 | キャノピー グロウス コーポレイション | カンナビノイド誘導体 |
| US20230122510A1 (en) | 2019-11-26 | 2023-04-20 | Canopy Growth Corporation | Cannabinoid derivatives |
| US20230059582A1 (en) | 2019-12-09 | 2023-02-23 | Canopy Growth Corporation | Cannabinoid derivatives |
| US12617765B2 (en) | 2019-12-09 | 2026-05-05 | Canopy Growth Corporation | Cannabinoid derivatives |
-
2020
- 2020-11-25 US US17/780,047 patent/US12084407B2/en active Active
- 2020-11-25 JP JP2022530210A patent/JP2023503601A/ja active Pending
- 2020-11-25 WO PCT/CA2020/051607 patent/WO2021102567A1/en not_active Ceased
- 2020-11-25 EP EP20894617.8A patent/EP4065554A4/en not_active Withdrawn